Q fever

Q fever
Name	Q fever
Field	Infectious disease, Infectious disease, Internal medicine
Symptoms	Fever, headache, pneumonia, hepatitis
Onset	Acute or chronic
Duration	Variable
Causes	Coxiella burnetii
Diagnosis	Serology, polymerase chain reaction
Differential	Legionnaires' disease, Brucellosis, Tularemia
Treatment	Doxycycline, chronic infection regimens
Prevention	Vaccination (limited), animal reservoir control

Q fever is an infectious disease caused by an obligate intracellular bacterium associated with livestock and wildlife. It presents with diverse clinical syndromes including acute febrile illness, atypical pneumonia, and chronic endocarditis, and poses challenges for diagnosis, treatment, and public health control. The disease has been the subject of field investigations, laboratory research, and public health responses by organizations and institutions worldwide.

Signs and symptoms

Acute presentations frequently include high fever, severe headache, myalgia, and malaise; respiratory involvement can produce atypical pneumonia and pleuritic chest pain. Patients may develop hepatitis with elevated liver enzymes and jaundice or neurologic complications such as meningoencephalitis in severe cases. Chronic manifestations most often present as culture-negative endocarditis in patients with preexisting valvular disease or vascular grafts; immunocompromised hosts may progress to osteomyelitis or chronic fatigue-like syndromes. Clinical evaluation often parallels workups used in Centers for Disease Control and Prevention, World Health Organization outbreak reports, and case series published by tertiary centers such as Johns Hopkins Hospital and Mayo Clinic.

Cause (Etiology)

The etiologic agent is Coxiella burnetii, a small, Gram-negative, obligate intracellular bacterium first described in studies involving field researchers and clinicians. The organism’s spore-like small-cell variant allows environmental persistence, enabling transmission from animal reservoirs including sheep, goats, cattle, and wild mammals. Molecular epidemiology has linked strains to outbreaks investigated by national reference laboratories, including those at Public Health England, Institut Pasteur, and National Institutes of Health research programs. Genetic and proteomic studies conducted at institutions such as Harvard University, University of Oxford, and ETH Zurich have characterized virulence determinants and antigenic phases relevant to vaccine development.

Transmission and epidemiology

Transmission commonly occurs via inhalation of aerosols contaminated with birth products, urine, feces, or wool from infected animals; unpasteurized milk and direct contact are less common routes. Outbreak investigations—such as events analyzed by teams from RIVM and European Centre for Disease Prevention and Control—demonstrate how farm practices, abattoir exposures, and windborne spread can produce large community clusters. Occupational risk groups include veterinarians, abattoir workers, farmers, and laboratory personnel; occupational health policies from organizations like Occupational Safety and Health Administration and Health and Safety Executive address exposure controls. Global epidemiology shows variable seroprevalence in regions studied by Australian National University, University of Amsterdam, and surveillance systems in France, Netherlands, Qatar, and United States military cohorts.

Pathophysiology and diagnosis

Coxiella burnetii invades host cells—particularly monocytes and macrophages—using intracellular survival strategies in acidic phagolysosomal compartments; inflammatory responses involve cytokines characterized in studies at Sloan Kettering Institute and Karolinska Institutet. Diagnosis integrates serologic testing for phase I and phase II antibodies by immunofluorescence assay and enzyme-linked immunosorbent assay, alongside molecular detection by PCR targeting multicopy genes, as validated in reference labs at Centers for Disease Control and Prevention and Pasteur Institute. Imaging modalities such as chest radiography and computed tomography are used for pulmonary disease assessment in centers like Massachusetts General Hospital and Cleveland Clinic, while echocardiography is essential for detecting endocarditis in cohorts managed at Baylor College of Medicine and Mount Sinai Hospital.

Treatment and management

First-line therapy for acute infection is doxycycline, with treatment regimens informed by clinical trials and guidelines from professional bodies such as Infectious Diseases Society of America and national health agencies. Chronic Q fever, particularly endocarditis or vascular infection, requires prolonged combination therapy—often doxycycline with hydroxychloroquine—and sometimes surgical intervention coordinated by multidisciplinary teams at institutions like Stanford Health Care and University College London Hospitals. Management of pregnant patients, pediatric cases, and antimicrobial stewardship considerations has been addressed in position papers from American Academy of Pediatrics and obstetric units at University of California, San Francisco.

Prevention and control

Control strategies emphasize vaccination of high-risk animal and human populations where available, pasteurization of dairy products, biosecurity on farms, and occupational protective measures promulgated by agencies such as Food and Agriculture Organization and World Organisation for Animal Health. Outbreak containment relies on coordinated responses involving national public health authorities, local veterinary services, and environmental monitoring teams that draw on expertise from European Food Safety Authority and national laboratories like CSIRO and Friedrich Loeffler Institute. Public education, reporting systems, and veterinary vaccination programs implemented in parts of Australia and Netherlands illustrate integrated One Health approaches advocated by One Health Commission.

History and research

Descriptions of the disease emerged from field investigations in the 1930s involving military and civilian researchers; early work at institutions such as Rockefeller Institute and Walter Reed Army Institute of Research defined the organism and immune responses. Major outbreak investigations—documented in reports from Netherlands Ministry of Health and case series from France—spurred development of diagnostic assays, inactivated vaccines used in specific populations, and contemporary molecular studies at universities including University of Cambridge, University of Sydney, and Imperial College London. Ongoing research priorities funded by bodies like National Science Foundation, European Research Council, and National Institute for Health Research include improved vaccines, rapid diagnostics, and better understanding of chronic sequelae studied in consortia involving Wellcome Trust and translational groups at Johns Hopkins University.

Category:Bacterial diseases